Ubs Asset Management Americas Inc Atri Cure, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,202,867 shares of ATRC stock, worth $37.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,202,867
Previous 2,196,914
45.25%
Holding current value
$37.9 Million
Previous $70.9 Million
44.38%
% of portfolio
0.01%
Previous 0.02%
Shares
30 transactions
Others Institutions Holding ATRC
# of Institutions
225Shares Held
52.2MCall Options Held
33.5KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA4.84MShares$152 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$145 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA3.97MShares$125 Million0.02% of portfolio
-
Alliancebernstein L.P. New York, NY3.57MShares$113 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3.06MShares$96.4 Million1.62% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.46B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...